Chandra is an Investment Advisor at HBM Partners, a global investor in private biotech, pharma, medical device and diagnostics companies. Click here for full-bio.

Ulrich is a Managing Partner at CIVITAS International, a leading European executive search firm with focus in pharma, biotech, and medical devices/diagnostics. Click here for full-bio.

Aleksandar is a Principal at Roland Berger Strategy Consultants in Zurich, responsible for the Competence Center Pharma & Healthcare in Switzerland.  Click here for full-bio.

 Marc is Managing Director of the European branch of Greater Than One, a digital agency specialized in online healthcare and pharmaceutical marketing.  Click here for full-bio.

Steven is a Director at Creativ-Ceutical, a consultancy providing pricing, market access, health economic and outcomes research services to the life science industry.  Click here for full-bio.

Prof. Stephen Chick

Stephen Chick is a Professor of Technology and Operations Management at INSEAD. He received his MSc and PhD from the University of California at Berkeley in Industrial Engineering and Operations Research and his BSc in Mathematics from Stanford University. Prior to joining INSEAD, he taught process modeling, simulation and information systems as a faculty member at the University of Michigan.  Click here for full-bio.

Frank Verwiel, M.D.

Frank Verwiel, M.D., President and Chief Executive Officer of Axcan Pharma Inc., joined the Company in 2005 with more than 20 years of experience in the pharmaceutical industry. Dr. Verwiel also serves on the Board of Directors of Axcan Intermediate Holdings Inc., the parent company of Axcan. Click here for full-bio.